InsidersTradesSigma
Follow the 나이벡 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 나이벡 has published 1 insider filings. Market capitalisation: €218.5bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 나이벡. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.